TrialsAlert vs CenterWatch: The Best CenterWatch Alternative for Patients (2026)
Patient briefings vs industry intelligence
By Victor Lafforgue, Founder of TrialsAlert. Last updated April 2026. TrialsAlert is our product. See our editorial policy.
CenterWatch has served the clinical research industry since 1994 with benchmark reports, FDA guidance, training resources, and over 40,000 trial listings. It is a powerful tool for pharmaceutical sponsors, contract research organizations, and research sites. But if you are a patient or caregiver tracking a medical condition and you are looking for a CenterWatch alternative that speaks to patients rather than the industry, TrialsAlert is designed for exactly that audience. This page compares both services side by side so you can decide which one fits your needs.
Feature comparison
| Feature | TrialsAlert | CenterWatch |
|---|---|---|
| Data source | ClinicalTrials.gov API v2 (synced daily) | ClinicalTrials.gov plus proprietary industry intelligence |
| Update frequency | Scans daily; weekly briefing delivered every Friday | Trial listings updated daily; reports published periodically |
| AI scoring | Six dimensions of patient-relevant impact | None |
| Alert delivery | Weekly email briefing per tracked condition | None (manual browsing; industry newsletters available) |
| Pricing | From EUR 11/month (Single). EUR 19/month (Universal). 27% off quarterly. | Free trial listings; premium reports and training are paid |
| Patient vs researcher focus | Built exclusively for patients and caregivers | Primarily industry professionals; also offers patient-facing listings |
| Number of conditions | 400,000+ trials tracked; 1 or 3 conditions per subscription | 40,000+ listed trials browsable; no subscription model |
| Language support | English and French UI; briefings in plain English | English; clinical and industry language |
What is CenterWatch?
CenterWatch is a clinical trial information platform that has operated since 1994. It combines trial listings with industry intelligence: benchmark reports, regulatory guidance, training resources, and thought leadership content. The platform serves a dual audience. Patients can browse trial listings for free, and industry professionals (sponsors, CROs, research sites) access premium reports and training materials behind a paywall. CenterWatch's patient-facing side is a search interface similar to ClinicalTrials.gov. Its primary differentiator is the industry intelligence layer, including metrics on trial enrollment, site performance, and regulatory trends, that matters to people working inside clinical research.
How is TrialsAlert different from CenterWatch?
CenterWatch is primarily an industry information platform that also offers patient-facing trial listings. TrialsAlert is built exclusively for patients and caregivers, and the difference shows in every design decision. TrialsAlert explains trials in plain language, classifies them by patient impact rather than industry metrics, delivers proactive weekly briefings so no searching is required, and generates reports formatted for patient-doctor conversations. CenterWatch's strength is industry intelligence: benchmark reports, FDA guidance, and operational insights for sponsors and research sites. TrialsAlert does not produce benchmark reports or training content. It is narrower by design because its audience is narrower.
Who should choose CenterWatch
Choose CenterWatch if you work in clinical research and need operational intelligence. Industry benchmark reports (enrollment rates, site performance, protocol complexity metrics), FDA regulatory updates, CME-eligible training content, and historical trial intelligence are all genuinely useful for sponsors, CROs, site coordinators, medical affairs teams, and regulatory professionals. CenterWatch is also a reasonable free directory for patients who are comfortable searching clinical trial listings directly and who do not need AI-scored classifications or plain-English explanations. If you already use ClinicalTrials.gov, CenterWatch overlaps with it significantly for patient browsing, so most patients do not need both.
Who should choose TrialsAlert
Choose TrialsAlert if you are a patient or caregiver tracking a specific medical condition and you want automated, plain-language research updates. TrialsAlert is built for the user who says: "I don't have hours a week to sort through clinical trial listings. I want the research that matters to me, scored and classified, explained in plain English, and delivered every Friday." The doctor-ready report feature is particularly valuable for patients who want to have informed conversations with their physician about specific trials. If your need is ongoing condition monitoring rather than industry intelligence, TrialsAlert is the right CenterWatch alternative for that use case.
Frequently asked questions
Is TrialsAlert cheaper than CenterWatch for patients?
Both are low-cost or free for basic patient use. CenterWatch's patient-facing trial listings are free, but the service is not designed to deliver ongoing updates. TrialsAlert costs EUR 11 per month (or EUR 24 per quarter) for monitoring one condition, which is the core use case for patients who want weekly briefings rather than a searchable directory.
Does TrialsAlert include industry benchmark data like CenterWatch?
No. TrialsAlert is patient-facing and does not publish industry benchmarks, enrollment metrics, or regulatory intelligence. If you need that, CenterWatch is the right tool. TrialsAlert focuses on translating ClinicalTrials.gov activity into plain English for patients and caregivers.
Can I use CenterWatch and TrialsAlert together?
If you work in clinical research but also have a personal condition you are tracking, yes. Use CenterWatch for industry intelligence and TrialsAlert for your personal monitoring. The two have almost no functional overlap in the use cases where each shines.
Does TrialsAlert provide training or CME credit?
No. TrialsAlert is a monitoring service, not a training platform. CenterWatch offers training and CME content as a separate revenue line. If you need continuing medical education credits, CenterWatch is the appropriate choice.
The bottom line
CenterWatch is a serious industry intelligence platform with a patient-facing directory on the side. TrialsAlert is a focused patient monitoring service. If you work in clinical research or need benchmark reports, choose CenterWatch. If you are a patient or caregiver who wants automated weekly research briefings for a specific condition, TrialsAlert is the CenterWatch alternative built for you.